Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ELVN
#1719
Enliven Therapeutics, Inc. Common Stock
29.690
0
+2.63%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+2.63%
Mudança mensal
+13.58%
Mudança em 6 meses
+43.71%
Mudança anual
+43.71%
Fechamento anterior
28.930
0
Open
29.700
0
Bid
Ask
Low
29.690
0
High
29.700
0
Volume
140
Mercados
Ações
Cuidados de saúde
ELVN
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
17.58 M
26.29 M
26.23 M
41.35 M
49 M
—
Valuation ratios
Enterprise value
—
—
—
515.94 M
978.48 M
4.02 B
Price to earnings ratio
—
—
—
-7.41
-11.9
-43.31
Price to sales ratio
—
—
—
—
96.28 K
—
Price to cash flow ratio
—
—
—
8.64
14.47
56.17
Price to book ratio
—
—
—
2.15
3.42
5.64
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.46
0.55
0.02
0.26
0.27
0.26
Return on equity %
0.49
0.6
0.02
0.29
0.29
0.27
Return on invested capital %
51.61 K
33.32 K
156.69
2 319.69
1 935.13
2 536.97
Gross margin %
—
—
100
—
100
—
Operating margin %
—
—
4 562.5
—
950.49 K
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
9 300
—
809.31 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.47
12.86
48.98
10.28
19.99
106.58
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
0
—
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
1.35
1.72
1.55
1.39
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
3.34
7.12
6.66
29.55
Net current asset value per share
—
—
3.4
7.49
6.76
29.92
Tangible book value per share
—
—
3.42
6.92
6.58
29.38
Working capital per share
—
—
3.33
6.76
6.42
28.78
Book value per share
—
—
3.42
6.92
6.58
29.38
Notícias
Diretor da Enliven Therapeutics vende US$ 32 mil em ações
Heyman, Enliven Therapeutics director, sells $32k in stock
Lyssikatos, CSO da Enliven Therapeutics, vende ações no valor de US$ 145 mil
Lyssikatos, Enliven Therapeutics CSO, sells $145k in shares
Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock
Diretor da Enliven Therapeutics, Heyman vende ações no valor de US$ 32.901
Enliven Therapeutics director Heyman sells $32,901 in stock
Anish Patel, COO of Enliven Therapeutics, sells $1.35m in ELVN
Enliven Therapeutics: Springing Into 2026 With Data, But I'm Still Cautious
Diretor científico da Enliven Therapeutics vende US$ 3,47 milhões em ações
Enliven Therapeutics CSO Lyssikatos sells $3.47 million in shares
Ações da Enliven Therapeutics atingem máxima de 52 semanas a US$ 25,64